Paper498152
Nephrotoxicity of cis-dichlorodiammineplatinum(II).
Krakoff IH. Cancer Treat Rep, 1979. Cited by 195 papers, by iCite.
Cite this record
ConductScience Library. Nephrotoxicity of cis-dichlorodiammineplatinum(II). Papers, record 498152. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/498152
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cisplatin | Major topic |
| Kidney | Major topic |
| Animals | |
| Humans | |
| Kidney Tubular Necrosis, Acute | |
| Mannitol | |
| Neoplasms |
Source PubMed
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 195 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 22961311 | Antineoplastic drug, carboplatin, protects mice against visceral leishmaniasis. | Parasitol Res | 2013 | https://conductscience.org/library/papers/22961311 | PubMed |
| 22312548 | Optimizing Liposomal Cisplatin Efficacy through Membrane Composition Manipulations. | Chemother Res Pract | 2011 | https://conductscience.org/library/papers/22312548 | PubMed |
| 20668574 | Comparison of the cytotoxic effects of Juniperus sabina and Zataria multiflora extracts with Taxus baccata extract and Cisplatin on normal and cancer cell lines. | Pharmacogn Mag | 2010 | https://conductscience.org/library/papers/20668574 | PubMed |
| 11308249 | A phase I study in paediatric patients to evaluate the safety and pharmacokinetics of SPI-77, a liposome encapsulated formulation of cisplatin. | Br J Cancer | 2001 | https://conductscience.org/library/papers/11308249 | PubMed |
| 8281624 | Combination chemotherapy of human ovarian xenografts with intraperitoneal liposome-incorporated valinomycin and cis-diamminedichloroplatinum(II). | Cancer Chemother Pharmacol | 1994 | https://conductscience.org/library/papers/8281624 | PubMed |
| 8080724 | Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatin. | Br J Cancer | 1994 | https://conductscience.org/library/papers/8080724 | PubMed |
| 7737234 | A comparative study of uranyl nitrate and cisplatin-induced renal failure in rat. | Eur J Drug Metab Pharmacokinet | 1994 | https://conductscience.org/library/papers/7737234 | PubMed |
| 7720180 | Long-term platinum excretion in patients treated with cisplatin. | Cancer Chemother Pharmacol | 1995 | https://conductscience.org/library/papers/7720180 | PubMed |
| 7634382 | Effects of sodium thiosulfate on the pharmacokinetics of unchanged cisplatin and on the distribution of platinum species in rat kidney: protective mechanism against cisplatin nephrotoxicity. | Cancer Chemother Pharmacol | 1995 | https://conductscience.org/library/papers/7634382 | PubMed |
| 6889884 | Effects of cisplatin on different haemopoietic progenitor cells in mice. | Br J Cancer | 1982 | https://conductscience.org/library/papers/6889884 | PubMed |
| 6392147 | A phase I trial of cis-diammine-1,1-cyclobutane dicarboxylate platinum II (Carboplatin, CBDCA, JM-8) with a single dose every five week-schedule. | Invest New Drugs | 1984 | https://conductscience.org/library/papers/6392147 | PubMed |
| 6350313 | Toxicity associated with combination chemotherapy for osteosarcoma: a report of the cooperative osteosarcoma study (COSS 80). | J Cancer Res Clin Oncol | 1983 | https://conductscience.org/library/papers/6350313 | PubMed |
| 6293731 | The effects of dimercaptosuccinic acid and other chelating agents on the retention of platinum in the rat kidney after treatment with cisplatin. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/6293731 | PubMed |
| 6254081 | Effect of diethyldithiocarbamate rescue on tumor response to cis-platinum in a rat model. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6254081 | PubMed |
| 6176753 | [Side-effects of polychemotherapy in metastatic testicular neoplasms (author's transl)]. | Klin Wochenschr | 1982 | https://conductscience.org/library/papers/6176753 | PubMed |
| 4053265 | Evaluation of the nephrotoxicity of iproplatin (CHIP) in comparison to cisplatin by the measurement of urinary enzymes. | Cancer Chemother Pharmacol | 1985 | https://conductscience.org/library/papers/4053265 | PubMed |
| 3888432 | The effect of captopril on renal function in patients during the first cis-diamminedichloroplatinum II infusion. | Cancer Chemother Pharmacol | 1985 | https://conductscience.org/library/papers/3888432 | PubMed |
| 3835175 | Renal function, serum calcium and magnesium during treatment of advanced bladder carcinoma with cis-dichlorodiamineplatinum: impact of tumour site, patient age and magnesium suppletion. | Int Urol Nephrol | 1985 | https://conductscience.org/library/papers/3835175 | PubMed |
| 3698175 | Inhibition of cis-diamminedichloroplatinum (II)--induced renal toxicity in the rat. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3698175 | PubMed |
| 3542269 | Urinary beta 2-microglobulin: early indicator of high dose cisdiamminedichloroplatinum nephrotoxicity? Influence of furosemide. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3542269 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/498152
GET https://conductscience.org/api/papers/v1/498152/cited_by?page=2